2019
DOI: 10.1007/s13668-019-00291-3
|View full text |Cite
|
Sign up to set email alerts
|

Premixed vs Compounded Parenteral Nutrition: Effects of Total Parenteral Nutrition Shortage on Clinical Practice

Abstract: Purpose of Review Drug shortages continue to impact our patients with intestinal failure and their ability to receive nutrition. ASPEN guidelines address the management of certain shortages in compounded total parenteral nutrition (TPN); however, some institutions have utilized premixed total parenteral nutrition (pTPN) in place of TPN. Recent Findings Premixed TPN appears to be as safe, if not safer, as compounded TPN when comparing the risk of bloodstream infection. However, there is an increased use of supp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
4
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 27 publications
(31 reference statements)
0
4
0
1
Order By: Relevance
“…Provide MCB-PN for Home PN (HPN) support. Patients receiving long-term PN, often started at the hospital with compounded PN and then administered at home after stabilizing the case and are generally provided with MCB-PN due to the stability and easy administration (Grade 1C) (Bonnes et al, 2019).…”
Section: Resultsmentioning
confidence: 99%
“…Provide MCB-PN for Home PN (HPN) support. Patients receiving long-term PN, often started at the hospital with compounded PN and then administered at home after stabilizing the case and are generally provided with MCB-PN due to the stability and easy administration (Grade 1C) (Bonnes et al, 2019).…”
Section: Resultsmentioning
confidence: 99%
“…O uso de formulações de NP comerciais prontas para uso é encorajado como uma opção terapêutica pelas diretrizes nacionais e internacionais e estudos sugerem que seu uso resulte em potenciais benefícios econômicos e menores taxas infecções da corrente sanguínea nos pacientes 6,7 . Ainda assim, observamos que a utilização de formulações manipuladas de NP continua sendo prática comum nos hospitais e seu uso ocorreu em mais da metade dos casos avaliados.…”
Section: Discussionunclassified
“…While various 3-chamber PN formulations have been available for more than 2 decades in Europe, the first 3-chamber PN formulation was not approved by the US Food and Drug Administration until 2014. 2,3 formulation. 4 Furthermore, a cost analysis of data from more than 400 US hospitals revealed a reduced costs when using MCB PN compared to customized PN, based on underlying reduced risk of infection.…”
Section: Introductionmentioning
confidence: 99%
“…While various 3-chamber PN formulations have been available for more than 2 decades in Europe, the first 3-chamber PN formulation was not approved by the US Food and Drug Administration until 2014. 2,3…”
Section: Introductionmentioning
confidence: 99%